Journal article icon

Journal article

A review of the first year of Medicare coverage of erythropoietin.

Abstract:

Recombinant human erythropoietin (rHuEPO) is a new drug for treating anemia associated with end stage renal disease (ESRD). In a study of rHuEPO diffusion, costs, and effectiveness, we analyze ESRD program data and all claims submitted to Medicare for reimbursement of rHuEPO administered to ESRD dialysis patients. Access to rHuEPO was rapid and extensive during the first year of Medicare coverage. Dosing of rHuEPO and achieved hematocrit were lower than expected based on the results of clinic...

Expand abstract

Actions


Authors


Expand authors...
Journal:
Health care financing review
Volume:
15
Issue:
3
Pages:
83-102
Publication date:
1994-01-01
EISSN:
1554-9887
ISSN:
0195-8631
URN:
uuid:6995474b-037d-4e1f-87ff-2837af53bde3
Source identifiers:
359135
Local pid:
pubs:359135

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP